首页> 外文期刊>Journal of the American Pharmaceutical Association: APhA >Overactive bladder patients and role of the pharmacist.
【24h】

Overactive bladder patients and role of the pharmacist.

机译:膀胱过度活动症患者和药剂师的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To summarize the prevalence, quality of life (QOL) implications, cost of illness, and pharmacotherapy of overactive bladder (OAB), and to describe the pharmacist's role in the management of patients with OAB. DATA SOURCES: Articles published between 1990 and 2001 identified through a MEDLINE search using the terms overactive bladder, unstable bladder, urinary incontinence, prevalence, cost of illness, quality of life, drug therapy, pharmacist, and pharmacy in various combinations. STUDY SELECTION: All studies providing information on OAB or urinary incontinence were retrieved. DATA EXTRACTION: By the authors. DATA SYNTHESIS: Published prevalence and cost studies focus primarily on urinary incontinence, which is only one possible symptom of OAB. Reported prevalence rates of urge and mixed incontinence in the United States range from 3% to 8% and 5% to 37%, respectively, and the highest prevalence has been found in geriatric and psychogeriatric populations. Associated costs are substantial. Total costs of OAB in the United States were estimated to be
机译:目的:总结过度活动性膀胱(OAB)的患病率,生活质量(QOL)的影响,疾病成本和药物治疗,并描述该药剂师在OAB患者管理中的作用。数据来源:1990年至2001年之间发表的文章通过MEDLINE搜索使用膀胱过度活跃症,膀胱不稳定,尿失禁,患病率,患病成本,生活质量,药物治疗,药剂师和药房的各种组合来识别。研究选择:检索所有提供OAB或尿失禁信息的研究。数据提取:作者。数据综合:已发表的患病率和费用研究主要集中于尿失禁,这只是OAB的一种可能症状。在美国,报告的急迫和混合性尿失禁的患病率分别为3%至8%和5%至37%,在老年和老年精神病人群中发现的患病率最高。相关费用很高。在美国,OAB的总成本估计为

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号